BMJ Open Respiratory Research

Papers
(The H4-Index of BMJ Open Respiratory Research is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Evaluation of the Norwegian version of the Dyspnoea-12 questionnaire in patients with COPD85
Bagasse dust exposure and chronic respiratory symptoms among workers in the Metehara and Wonji sugar factories in Ethiopia: a longitudinal study design80
Genomic testing for children with interstitial and diffuse lung disease (chILD): parent satisfaction, understanding and health-related quality of life60
Differences in risk indicators associated with electronic cigarette use and tobacco smoking among adolescents and young people in Nigeria52
Differences in uni-dimensional breathlessness measures and thresholds for clinical response in a randomised controlled trial in people with chronic breathlessness: an exploratory study46
Comparing the impact of targeting limited driving pressure to low tidal volume ventilation on mortality in mechanically ventilated adults with COVID-19 ARDS: an exploratory target trial emulation44
Comparison of the efficacy of novel two covering methods for spontaneous pneumothorax: a multi-institutional study40
Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severities39
Methamphetamine-associated pulmonary arterial hypertension: data from the national biological sample and data repository for pulmonary arterial hypertension (PAH Biobank)35
Association between birth weight and chronic obstructive pulmonary disease in the UK Biobank: a prospective cohort study35
Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire33
Effect of a home-based inspiratory muscle training programme on functional capacity in postdischarged patients with long COVID: the InsCOVID trial31
Exploring the predictors and barriers to accepting smoking cessation support within a targeted lung health check setting30
Chronic obstructive pulmonary disease is a risk factor for non-tuberculous mycobacterial pulmonary disease: a population-based matched cohort study29
Serum KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients with COVID-1925
Withdrawal of inhaled corticosteroids from patients with COPD with mild or moderate airflow limitation in primary care: a feasibility randomised trial25
Hospital-level variation in practices and outcomes for patients with severe acute exacerbations of idiopathic pulmonary fibrosis: a retrospective multicentre cohort study24
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases23
Temperature synchronisation of circadian rhythms in primary human airway epithelial cells from children23
Impact of early caffeine administration on respiratory outcomes in very preterm infants initially receiving invasive mechanical ventilation23
What if… your research is suddenly affiliated with a tobacco manufacturing company?22
Association of high-sensitivity CRP and FEV1%pred: a study on non-pulmonary disease in a population in Beijing, China22
Rate of severe exacerbations, healthcare resource utilisation and clinical outcomes in patients with COPD in low-income and middle-income countries: results from the EXACOS International Study22
0.21912407875061